Immunotherapy with a standardized dermatophagoides pteronyssinus extract. V. Duration of the efficacy of immunotherapy after its cessation

Allergy: European Journal of Allergy and Clinical Immunology

Volumn 51, Issue 6, 1996, Pages 430-433

  Des Roches, A ^a   Paradis, L ^a   Knani, J ^a   Hejjaoui, A ^a   Dhivert, H ^a   Chanez, P ^a   Bousquet, J ^a  

^a HÔPITAL ARNAUD DE VILLENEUVE   (France)

Author keywords

Dermatophagoides pteronyssinus; duration; efficacy; immunotherapy; mites; standardized allergens

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; HOUSE DUST ALLERGEN; IMMUNOGLOBULIN E ANTIBODY;

ADOLESCENT; ADULT; ALLERGIC ASTHMA; ALLERGIC RHINITIS; ARTICLE; CHILD; CLINICAL ARTICLE; CLINICAL PROTOCOL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; FEMALE; FORCED EXPIRATORY VOLUME; GRASS POLLEN; HUMAN; IMMUNOTHERAPY; INHALATIONAL DRUG ADMINISTRATION; MALE; PRIORITY JOURNAL; RELAPSE; SKIN TEST;

EID: 0029834133     PISSN: 01054538     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1398-9995.1996.tb00155.x     Document Type: Article

References (16)

1. Golden DB, Addison BI, Gadde J, Kagey-Sobotka A, Valentine MD, Lichtenstein LM. Prospective observations on stopping prolonged venom immunotherapy. J Allergy Clin Immunol 1989;84:162-7.
2. Bousquet J, Knani J, Velasquez G, Menardo JL, Guilloux L, Michel FB. Evolution of sensitivity to Hymenoptera venom in 200 allergic patients followed for up to 3 years. J Allergy Clin Immunol 1989;84:944-50.
3. Mosbech H, Østerballe O. Does the effect of immunotherapy last after termination of treatment? Follow-up study in patients with grass pollen rhinitis. Allergy 1988;43:523-9.
4. Grammer LC, Shaughnessy MA, Suszko IM, Shaughnessy JJ, Patterson R. Persistence of efficacy after a brief course of polymerized ragweed allergen: a controlled study. J Allergy Clin Immunol 1984;73:484-9.
5. Jarolim E, Poulsen LK, Stadler BM, et al. A long-term follow-up study of hyposensitization with immunoblotting. J Allergy Clin Immunol 1990;85:996-1004.
6. Price JF, Warner JO, Hey EN, Turner MW, Soothill JF. A controlled trial of hyposensitization with adsorbed tyrosine Dermatophagoides pteronyssinus antigen in childhood asthma: in vivo aspects. Clin Allergy 1984;14:209-19.
7. Smith A. Hyposensitization with Dermatophagoides pteronyssinus antigen: trial in asthma induced by house dust. BMJ 1971;4:204-6.
8. Bousquet J, Calvayrac P, Guerin B, et al. Immunotherapy with a standardized Dermatophagoides pteronyssinus extract. I. In vivo and in vitro parameters after a short course of treatment. J Allergy Clin Immunol 1985;76:734-44.
9. Hejjaoui A, Dhivert H, Michel FB, Bousquet J. Immunotherapy with a standardized Dermatophagoides pteronyssinus extract. IV. Systemic reactions according to the immunotherapy schedule. J Allergy Clin Immunol 1990;85:473-9.
10. Bousquet J, Maasch H, Martinot B, Hejjaoui A, Wahl R, Michel FB. Double-blind, placebo-controlled immunotherapy with mixed grass-pollen allergoids. II. Comparison between parameters assessing the efficacy of immunotherapy. J Allergy Clin Immunol 1988;82:439-46.
11. Bousquet J, Djoukadar F, Hewitt B, Guerin B, Michel FB. Comparison of the stability of a mite and a pollen extract stored in normal conditions of use. Clin Allergy 1985;15:29-35.
12. Knudson R, Slavin R, Lebowitz M, Burrows B. The maximum expiratory flow volume curve: normal standards, variability and effects of age. Am Rev Respir Dis 1976;113:587-600.
13. Bousquet J, Chanez P, Lacoste JY, et al. Asthma: a disease remodeling the airways. Allergy 1992;47:3-11.
14. Bousquet J, Hejjaoui A, Clauzel AM, et al. Specific immunotherapy with a standardized Dermatophagoides pteronyssinus extract. II. Prediction of efficacy of immunotherapy. J Allergy Clin Immunol 1988;82:971-7.
15. Bousquet J, Hejjaoui A, Soussana M, Michel FB. Doubleblind, placebo-controlled immunotherapy with mixed grasspollen allergoids. IV. Comparison of the safety and efficacy of two dosages of a high-molecular-weight allergoid. J Allergy Clin Immunol 1990;85:490-7.
16. Bousquet J, Guerin B, Michel FB. Design of protocols to evaluate the safety and efficacy of allergenic extracts. Arb Paul Ehrlich Inst Georg Speyer Haus Ferdinand Blum Inst Frankf A M 1987;80:213-28.